Colorectal Cancer
November 20
6 min read
Circulating tumor DNA (ctDNA) testing can identify molecular residual disease in patients with colorectal cancer who have no radiographic evidence of cancer following curative-intent treatment. Although its prognostic value is well established, questions remain about how best to use the results to guide treatment.